EDCTP open calls for Expressions of Interest (EoI) for the Scientific Committee

The Global Health EDCTP3 JU is accepting applications of EoI to join its Scientific Committee. The governance of the Global Health EDCTP3 JU is led by a Governing Board, in which both the EDCTP Association and the European Commission, representing the Union, have equal votes. The implementation of the programme is ensured by a programme office under the lead of an Executive Director. The Global Health EDCTP3 JU is to be advised by a Scientific Committee and a Stakeholders Group.

The Scientific Committee of the Global Health EDCTP3 JU has the following tasks:

  1.  advise on the scientific priorities to be addressed in the work programmes including on scope of calls for proposals, in line with the Strategic Research and Innovation Agenda and the Horizon Europe strategic planning;
  2. advise on the scientific achievements to be described in the annual activity report;
  3. suggest, in view of the progress of the Strategic Research and Innovation Agenda and individual actions, corrective measures or re-orientations to the governing board, where necessary;
  4. provide independent advice and scientific analysis on specific issues as requested by the governing board, in particular as regards developments in adjacent sectors or to support the assessment of applications of potential associated members and contributing partners;
  5. assist in the design of the strategic and scientific planning of the activities of the Global Health EDCTP3 Joint Undertaking;
  6. advise on strategies to foster synergies and partnerships with all stakeholders;
  7. contribute to the preparation of strategic and scientific documents relevant to the Global Health EDCTP3 Joint Undertaking, as required;
  8. provide strategic and scientific advice to the Global Health EDCTP3 Joint Undertaking and ensure the successful completion of on-going projects;
  9. identify strategic needs and priorities for accelerating the development of new or improved clinical interventions, including the required training, networking and capacity building to be undertaken to achieve those objectives;
  10. review the landscape of poverty-related and neglected diseases to identify the Global Health EDCTP3 Joint Undertaking’s role in partnership with other stakeholders to accelerate the development or improvement of interventions against those diseases;
  11. assess the state of global product development pathways and the critical path opportunities for future product development;
  12. provide advice on the review of any calls for proposals and other programmes;
  13. provide support and input on the monitoring and evaluation framework of the Global Health EDCTP3 Joint Undertaking, as well as in the monitoring of scientific outcomes and strategic impacts of the grants funded by the Global Health EDCTP3 Joint Undertaking;
  14. advise, assist and participate in Global Health EDCTP3 Joint Undertaking working groups, stakeholder meetings, EDCTP Forum and other relevant events.

Essential eligibility and selection criteria:

  • Candidate Members of the Scientific Committee shall meet the following essential eligibility criteria:
    •  University degree in a relevant scientific area, preferably at post-graduate level;
    • At least five years of professional experience in the relevant scientific area after having obtained the above-mentioned degree;
  • Candidate Members of the Scientific Committee shall meet the following specific eligibility criteria:
    • Proven competence and expertise in at least one of the following areas:
      • Product development and clinical research in infectious diseases affecting sub-Saharan Africa including HIV, tuberculosis, malaria, neglected infectious diseases, lower respiratory tract infections, diarrhoeal diseases, emerging and re-emerging infections, antimicrobial resistance as well as related co-morbidities
      • Epidemic preparedness research and response
      • Early warning, risk assessment and surveillance of emerging infectious diseases, climate crisis-related infectious disease and antimicrobial resistance infectious diseases and neglected tropical disease
      • Epidemiological research on infectious diseases
      • Implementation research for medical interventions in low and middle income countries, in particular in sub-Saharan Africa â–ª Clinical trial design and operations, biostatistics
      • Clinical pharmacology and pharmacokinetics
      • Mathematical modelling for infectious diseases and clinical health research
      • Clinical research Ethics and Regulatory affairs & Pharmacovigilance
      • Training and capacity development of researchers in clinical trial research in low-resource settings
      • Capacity building for medical research in developing countries 
      • Social science, community engagement and gender balance in research in low-resource settings
      • Health research systems and policy, translation of research findings into policy guidelines and adoption within public health systems
      • Health research data sharing, data access and governance
      • Climate and Health research 
      • Pharmaceutical Industry R&D experience
    • Very good command of written and spoken English
    • In addition, a record of previous participation in other scientific and/or technological advisory bodies, demonstrating the ability to look for consensus and to provide synthetic, wide-spectrum analyses would be considered an asset.

Read more here.

Applications deadline September 30, 2024.

SHARE

Upcoming opportunities